GU CONNECT has summarised the testicular cancer highlights from ESMO 2016 - Copenhagen for you.
Testicular cancer update by Assoc. Prof. Brian Costello
GU CONNECT has summarised the testicular cancer highlights from ESMO 2016 - Copenhagen for you.
Testicular cancer update by Assoc. Prof. Brian Costello
Brian A. Costello, M.D., M.S. is a Consultant in the Division of Medical Oncology at Mayo Clinic Rochester and is an Associate Professor of Oncology and Urology. He received his medical degree from the Medical College of Wisconsin and completed his internal medicine residency at the University of New Mexico School of Medicine. He then completed his medical oncology fellowship at Mayo Clinic. Dr Costello was subsequently a Mayo Clinic Scholar during which time he focused on early phase clinical trials and genitourinary malignancies. Dr Costello is currently the Chair of the Genitourinary Tumor Group of the Division of Medical Oncology at Mayo Clinic. He serves as a member of the NCCN Kidney Cancer Panel, the National Cancer Institute’s Renal Task Force, as well as the GU Cancers Core Committee of the Alliance for Clinical Trials in Oncology. He also previously served on the NCI Prostate Task Force from 2013 to 2016. He is actively involved in clinical and translational research and has a busy practice caring for patients with genitourinary cancers. Dr Costello is actively involved in early drug development, especially in genitourinary malignancies. He is the Lead Investigator of the NCI-sponsored Mayo Phase II Program and is a member of the NCI’s Investigational Drug Steering Committee.
An overview of the EMERALD subgroup analyses
A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC
Survey findings presented at ONS 2025 and published in the journal Healthcare
What to know, what to expect, and where to find support
Optimising 1st and 2nd line treatment
Optimising precision medicine for improved patient outcomes